Home › Autoimmune Diseases › Massachusetts › Boston

Autoimmune Diseases clinical trials in Boston, MA

13 studies for Autoimmune Diseases are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3

Boston Children's Hospital - Accepting Young Adults and Juvenile Patients, Boston

Ages 6 to 75 · All sexes · Updated Nov 13, 2026 · NCT06154252

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

RecruitingPhase 3

Boston Children's Cancer Center, Boston

Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT06056297

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

RecruitingPhase 3

Tufts Medical Center, Boston

Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07621809

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3

Massachusetts General Hospital, Boston

Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3

Massachusetts General Hospital, Boston

Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318

Testimonials and Navigation in Rheumatology

Recruiting

Brigham Women's Hospital, Boston

Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06469788

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

RecruitingPhase 1/2

Beth Israel Deaconess Medical Center, Boston

Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06359041

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

RecruitingPhase 1/2

Brigham and Women's Hospital, Boston

Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT04422912

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RecruitingPhase 1/2

Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Boston Children's Hospital - Accepting Young Adult and Adolescent Patients, Boston
and 1 more

Ages 12 to 65 · All sexes · Updated Oct 6, 2026 · NCT06121297